MedTrace Logo

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire

NCT01917175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 511

Last updated 2021-06-11

No results posted yet for this study

Summary

Set-up of a biobank for patients with an estimated date of infection seroconverters: store plasma and cells samples at initial contact and during follow-up for future analysis and analysis in international collaborative cohort seroconverters.

Conditions

  • HIV Infection

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Albert Kla Minga, MD, PhD · CMSDS, Abidjan, Côte d'Ivoire

  • Patrick Coffie, MD, PhD · Programme PACCI, Abidjan, Côte d'Ivoire

  • Charlotte Lewden, MD, PhD · Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Bordeaux, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-06-30
Primary Completion
2014-02-28
Completion
2018-09-30

Countries

  • Côte d’Ivoire

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917175 on ClinicalTrials.gov